世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034739

心血管治療薬の世界市場(2023-2027)

TechNavio

Global Cardiovascular Therapeutics Market 2023-2027

発刊日 2023/03/31

言語英語

体裁PDF/172ページ

ライセンス/価格172ページ

0000034739

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、心血管治療薬市場を分析します。

世界の心血管治療薬市場は、予測期間中に約7.32 %のCAGRで拡大し、2022年から2027年の間に377億7,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、心血管疾患のリスク要因の増加、高度な診断方法の利用可能性、高コレステロール血症の有病率の上昇によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 抗血栓薬
      ◇ 脂質異常症薬
      ◇ その他
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ アジア
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ その他の地域

本調査では、新規経口抗凝固薬(NOAC)の登場が、今後数年間の心血管治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、新たな病因の特定や冠動脈性心疾患(CHD)の罹患率の高さが、市場の大きな需要につながると考えられます。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 心血管治療薬の市場規模
  • 心血管治療薬の市場予測
  • 心血管治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な心血管治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Acutus Medical Inc.
    ➣ Amgen Inc.
    ➣ Astellas Pharma Inc.
    ➣ AstraZeneca Plc
    ➣ Aurobindo Pharma Ltd.
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ Dr Reddys Laboratories Ltd.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Johnson and Johnson Services Inc.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global cardiovascular therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global cardiovascular therapeutics market 2017 - 2021 ($ billion)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.3 Distribution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Antithrombotic drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
6.4 Hypolipidemic drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ billion)
Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 60: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ billion)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 India - Market size and forecast 2022-2027
Exhibit 95: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on India - Year-over-year growth 2022-2027 (%)
9.10 Russia - Market size and forecast 2022-2027
Exhibit 99: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Russia - Year-over-year growth 2022-2027 (%)
9.11 Mexico - Market size and forecast 2022-2027
Exhibit 103: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key offerings
Exhibit 118: Abbott Laboratories - Segment focus
12.4 Astellas Pharma Inc.
Exhibit 119: Astellas Pharma Inc. - Overview
Exhibit 120: Astellas Pharma Inc. - Product / Service
Exhibit 121: Astellas Pharma Inc. - Key news
Exhibit 122: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 123: AstraZeneca Plc - Overview
Exhibit 124: AstraZeneca Plc - Product / Service
Exhibit 125: AstraZeneca Plc - Key news
Exhibit 126: AstraZeneca Plc - Key offerings
12.6 Aurobindo Pharma Ltd.
Exhibit 127: Aurobindo Pharma Ltd. - Overview
Exhibit 128: Aurobindo Pharma Ltd. - Product / Service
Exhibit 129: Aurobindo Pharma Ltd. - Key offerings
12.7 Bayer AG
Exhibit 130: Bayer AG - Overview
Exhibit 131: Bayer AG - Business segments
Exhibit 132: Bayer AG - Key news
Exhibit 133: Bayer AG - Key offerings
Exhibit 134: Bayer AG - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 135: Boehringer Ingelheim International GmbH - Overview
Exhibit 136: Boehringer Ingelheim International GmbH - Business segments
Exhibit 137: Boehringer Ingelheim International GmbH - Key news
Exhibit 138: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 139: Boehringer Ingelheim International GmbH - Segment focus
12.9 Bristol Myers Squibb Co.
Exhibit 140: Bristol Myers Squibb Co. - Overview
Exhibit 141: Bristol Myers Squibb Co. - Product / Service
Exhibit 142: Bristol Myers Squibb Co. - Key news
Exhibit 143: Bristol Myers Squibb Co. - Key offerings
12.10 Daiichi Sankyo Co. Ltd.
Exhibit 144: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 145: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 146: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 148: Daiichi Sankyo Co. Ltd. - Segment focus
12.11 Dr Reddys Laboratories Ltd.
Exhibit 149: Dr Reddys Laboratories Ltd. - Overview
Exhibit 150: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 151: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 152: Dr Reddys Laboratories Ltd. - Segment focus
12.12 Eli Lilly and Co.
Exhibit 153: Eli Lilly and Co. - Overview
Exhibit 154: Eli Lilly and Co. - Product / Service
Exhibit 155: Eli Lilly and Co. - Key offerings
12.13 GlaxoSmithKline Plc
Exhibit 156: GlaxoSmithKline Plc - Overview
Exhibit 157: GlaxoSmithKline Plc - Business segments
Exhibit 158: GlaxoSmithKline Plc - Key news
Exhibit 159: GlaxoSmithKline Plc - Key offerings
Exhibit 160: GlaxoSmithKline Plc - Segment focus
12.14 Johnson and Johnson Services Inc.
Exhibit 161: Johnson and Johnson Services Inc. - Overview
Exhibit 162: Johnson and Johnson Services Inc. - Business segments
Exhibit 163: Johnson and Johnson Services Inc. - Key news
Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
12.15 Merck and Co. Inc.
Exhibit 166: Merck and Co. Inc. - Overview
Exhibit 167: Merck and Co. Inc. - Business segments
Exhibit 168: Merck and Co. Inc. - Key news
Exhibit 169: Merck and Co. Inc. - Key offerings
Exhibit 170: Merck and Co. Inc. - Segment focus
12.16 Pfizer Inc.
Exhibit 171: Pfizer Inc. - Overview
Exhibit 172: Pfizer Inc. - Product / Service
Exhibit 173: Pfizer Inc. - Key news
Exhibit 174: Pfizer Inc. - Key offerings
12.17 Viatris Inc.
Exhibit 175: Viatris Inc. - Overview
Exhibit 176: Viatris Inc. - Business segments
Exhibit 177: Viatris Inc. - Key offerings
Exhibit 178: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global cardiovascular therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Antithrombotic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antithrombotic drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Hypolipidemic drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hypolipidemic drugs - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Distribution Channel ($ billion)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Russia - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Mexico - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key offerings
Exhibits118: Abbott Laboratories - Segment focus
Exhibits119: Astellas Pharma Inc. - Overview
Exhibits120: Astellas Pharma Inc. - Product / Service
Exhibits121: Astellas Pharma Inc. - Key news
Exhibits122: Astellas Pharma Inc. - Key offerings
Exhibits123: AstraZeneca Plc - Overview
Exhibits124: AstraZeneca Plc - Product / Service
Exhibits125: AstraZeneca Plc - Key news
Exhibits126: AstraZeneca Plc - Key offerings
Exhibits127: Aurobindo Pharma Ltd. - Overview
Exhibits128: Aurobindo Pharma Ltd. - Product / Service
Exhibits129: Aurobindo Pharma Ltd. - Key offerings
Exhibits130: Bayer AG - Overview
Exhibits131: Bayer AG - Business segments
Exhibits132: Bayer AG - Key news
Exhibits133: Bayer AG - Key offerings
Exhibits134: Bayer AG - Segment focus
Exhibits135: Boehringer Ingelheim International GmbH - Overview
Exhibits136: Boehringer Ingelheim International GmbH - Business segments
Exhibits137: Boehringer Ingelheim International GmbH - Key news
Exhibits138: Boehringer Ingelheim International GmbH - Key offerings
Exhibits139: Boehringer Ingelheim International GmbH - Segment focus
Exhibits140: Bristol Myers Squibb Co. - Overview
Exhibits141: Bristol Myers Squibb Co. - Product / Service
Exhibits142: Bristol Myers Squibb Co. - Key news
Exhibits143: Bristol Myers Squibb Co. - Key offerings
Exhibits144: Daiichi Sankyo Co. Ltd. - Overview
Exhibits145: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits146: Daiichi Sankyo Co. Ltd. - Key news
Exhibits147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits148: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits149: Dr Reddys Laboratories Ltd. - Overview
Exhibits150: Dr Reddys Laboratories Ltd. - Business segments
Exhibits151: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits152: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits153: Eli Lilly and Co. - Overview
Exhibits154: Eli Lilly and Co. - Product / Service
Exhibits155: Eli Lilly and Co. - Key offerings
Exhibits156: GlaxoSmithKline Plc - Overview
Exhibits157: GlaxoSmithKline Plc - Business segments
Exhibits158: GlaxoSmithKline Plc - Key news
Exhibits159: GlaxoSmithKline Plc - Key offerings
Exhibits160: GlaxoSmithKline Plc - Segment focus
Exhibits161: Johnson and Johnson Services Inc. - Overview
Exhibits162: Johnson and Johnson Services Inc. - Business segments
Exhibits163: Johnson and Johnson Services Inc. - Key news
Exhibits164: Johnson and Johnson Services Inc. - Key offerings
Exhibits165: Johnson and Johnson Services Inc. - Segment focus
Exhibits166: Merck and Co. Inc. - Overview
Exhibits167: Merck and Co. Inc. - Business segments
Exhibits168: Merck and Co. Inc. - Key news
Exhibits169: Merck and Co. Inc. - Key offerings
Exhibits170: Merck and Co. Inc. - Segment focus
Exhibits171: Pfizer Inc. - Overview
Exhibits172: Pfizer Inc. - Product / Service
Exhibits173: Pfizer Inc. - Key news
Exhibits174: Pfizer Inc. - Key offerings
Exhibits175: Viatris Inc. - Overview
Exhibits176: Viatris Inc. - Business segments
Exhibits177: Viatris Inc. - Key offerings
Exhibits178: Viatris Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations

この商品のレポートナンバー

0000034739

TOP